Australia's Telix Pharmaceuticals announced on September 21, 2026 that it has agreed to acquire German radioisotope supplier ITM Isotope Technologies Munich SE on a transaction with a total value of up to US$2.35 billion.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.